Oxybuprocaine Hydrochloride

Oxybuprocaine Hydrochloride, also known as benoxinate, is a local anesthetic commonly used in ophthalmology. This article explores its application in various clinical trials, focusing on its effectiveness in reducing pain and discomfort during ocular procedures. We’ll examine how this drug is being studied for different eye-related conditions and surgical interventions.

Table of Contents

What is Oxybuprocaine Hydrochloride?

Oxybuprocaine Hydrochloride is a type of medication known as a local anesthetic. It’s primarily used in eye care to numb the surface of the eye temporarily. This drug is also known by other names, including Benoxinate and Benox[1]. The medication typically comes in the form of eye drops, usually in a 0.4% concentration[2].

Medical Uses

Oxybuprocaine Hydrochloride is used in various eye-related medical procedures and conditions:

  • Retinopathy of Prematurity (ROP) Screening: It’s used to reduce pain in premature infants during eye examinations for ROP, a condition that can affect the eyes of premature babies[1].
  • Cataract Surgery: The medication is used to provide topical anesthesia (numbing of the eye surface) during cataract operations[5].
  • Ocular Examinations: It’s used to numb the eye for various types of eye exams that might be uncomfortable without anesthesia[4].
  • Laser Eye Surgery: Oxybuprocaine is used as an anesthetic during procedures like SMILE (Small Incision Lenticule Extraction) for correcting myopia (short-sightedness)[6].

How is it Administered?

Oxybuprocaine Hydrochloride is typically administered as eye drops. The exact dosage and frequency can vary depending on the specific procedure or condition being treated. Here are some examples:

  • For cataract surgery, it may be instilled twice, 5 minutes apart, before the procedure[5].
  • In some studies, it’s given as two drops, one minute apart, before an eye examination[3].
  • For laser eye surgery, it’s used as an anesthetic during the procedure[6].

It’s important to note that this medication should only be administered by or under the supervision of a healthcare professional. Patients should not attempt to use this medication at home unless specifically instructed by their doctor.

Current Clinical Trials

Several clinical trials are currently investigating the use of Oxybuprocaine Hydrochloride:

  • A study is looking at its effectiveness in reducing pain during ROP screening in premature infants[1].
  • Another trial is comparing it to a gel form of another anesthetic (Chloroprocaine) for pediatric eye exams[3].
  • Researchers are also studying its effects on the eye’s microbial environment when used during examinations[4].

Potential Side Effects and Safety

While Oxybuprocaine Hydrochloride is generally considered safe when used as directed by a healthcare professional, it can have some side effects. These may include:

  • Temporary stinging or burning sensation when applied[3]
  • Potential changes to the eye’s microbial environment (the natural balance of microorganisms on the eye’s surface)[4]

It’s important to note that the safety of long-term or frequent use of topical anesthetics on the eye is still being studied. In one trial, researchers are investigating whether short-term use of preservative-free topical anesthetics after certain eye surgeries is safe for the cornea (the clear front part of the eye)[7].

Alternatives and Comparisons

While Oxybuprocaine Hydrochloride is widely used, there are other options for eye anesthesia:

  • Chloroprocaine: A study is comparing a gel form of this anesthetic to Oxybuprocaine eye drops for pediatric eye exams[3].
  • Proxymetacaine: This is another type of eye drop anesthetic sometimes used in combination with Oxybuprocaine[6].
  • Benoxinate: This is actually another name for Oxybuprocaine, so it’s the same medication[5].

The choice of anesthetic depends on various factors, including the specific procedure, the patient’s age and health condition, and the doctor’s preference. Your eye care professional will determine the most appropriate option for your specific situation.

Aspect Details
Primary Uses Topical anesthesia for eye procedures, pain reduction in ROP screening, ocular surface anesthesia for various examinations and surgeries
Formulation Typically used as 0.4% eye drops, sometimes in preservative-free unit-dose vials
Comparative Studies Being compared to other anesthetics like Chloroprocaine and artificial tears in various trials
Patient Groups Studied in premature infants, pediatric patients, and adults undergoing different eye procedures
Outcome Measures Pain scores (PIPP, VAS), patient comfort, surgeon satisfaction, corneal healing time, endothelial cell density
Safety Considerations Effects on corneal healing, potential impact on endothelial cells, short-term vs. long-term use safety

Ongoing Clinical Trials on Oxybuprocaine Hydrochloride

  • Cenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect

    Recruiting

    3 1 1
    Czechia France Germany Hungary Italy The Netherlands +2
  • Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Glaucoma Patients Undergoing Outpatient Needling Procedures

    Recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

    Not yet recruiting

    2 1 1 1
    France
  • Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Anesthesia in Glaucoma Patients Undergoing Needling Procedures

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Spain

Glossary

  • Retinopathy of Prematurity (ROP): An eye disorder that primarily affects premature infants, potentially leading to vision problems or blindness. It occurs when abnormal blood vessels grow in the retina.
  • Premature Infant Pain Profile (PIPP): A scoring system used to assess pain in premature infants. It considers factors like heart rate, oxygen saturation, and facial expressions to quantify pain levels.
  • Photorefractive Keratectomy (PRK): A type of laser eye surgery used to correct nearsightedness, farsightedness, and astigmatism by reshaping the cornea.
  • Endothelial Cell Density (ECD): A measure of the number of cells in the innermost layer of the cornea, which is important for maintaining corneal clarity and function.
  • Topical Anesthesia: The application of anesthetic agents directly to a body surface to numb a specific area, in this context, the eye surface.
  • Fundus Examination: An examination of the back of the eye, including the retina, optic disc, and blood vessels, typically performed during eye check-ups or specific eye condition screenings.
  • Slit Lamp Examination (SLE): A detailed examination of the eye's structures using a special microscope with a bright light, allowing the doctor to view the eye's anterior and posterior segments.

References

  1. https://clinicaltrials.gov/study/NCT06461975
  2. https://clinicaltrials.gov/study/NCT05666362
  3. https://clinicaltrials.gov/study/NCT05926258
  4. https://clinicaltrials.gov/study/NCT04193774
  5. https://clinicaltrials.gov/study/NCT03933280
  6. https://clinicaltrials.gov/study/NCT02528123
  7. https://clinicaltrials.gov/study/NCT05733741